MASS: 908 Devices EV/EBITDA Multiple

Corporate emblem and logo of 908 Devices (MASS)

908 Devices Inc. (MASS) develops compact mass spectrometers, utilizing proprietary microchips to displace bulky systems. This chart of stock quotes on GURU.Markets demonstrates an EV/EBITDA multiple of 0.00. Growth is driven by orders from intelligence agencies, forensic specialists, and pharmaceutical companies. Meanwhile, high product margins are offset by significant research and logistics costs, which constrain the operating leverage.

908 Devices Corporation - MASS Enterprise Value to EBITDA Ratio (period 11/23/2025 - 11/10/2026)

Summary analytical data breakdowns for 908devices.com (MASS)

- stock price and consensus target price:
Stock Quotes 908 Devices Corp|MASS - Analyst Forecast Prices
- market capitalization information:
Market Capitalization 908 Devices Corporation|MASS - Company Buyout Price
- issuer book value statistics:
Book Value per Share 908 Devices|MASS - Company Net Assets|Market Cap to Net Assets Ratio 908devices.com|MASS - Aggregate Asset Value
- company liabilities and liquidity data:
Debt to Equity 908 Devices Inc.|MASS - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital 908 Devices|MASS - Company Cumulative Debt|Debts to Book Capitalization 908 Devices Corporation|MASS - Company Long-Term Indebtedness|Company Short-Term Debts 908 Devices|Quick Ratio 908devices.com
- financial results and valuation multiples details:
MASS - Net Income|Projected Future Earnings 908 Devices Inc.|MASS - P/E Multiple|Future Price to Earnings 908 Devices Inc.|MASS - Price/Earnings to Growth Ratio|Enterprise Value to EBITDA Ratio 908 Devices Corporation|MASS - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) 908 Devices|MASS - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months 908devices.com|MASS - Net earnings per share change in current year|Expected earnings per share growth for next year 908 Devices Inc.
Initial company analysis:908 Devices Corp MASS
Original product of 908devices.com

Investors must isolate hidden debt risks for 908 Devices Inc. (MASS) when assessing capital. The absence of downtime and stable calibration of mass spectrometers confirm high operational efficiency in production. This Enterprise Value to EBITDA multiple compares the total business price, including debt, against its EBITDA to reveal excessive leverage. Analyzing this curve confirms the stability of the company's financial model.

Competitor analysis for 908 Devices Inc.

Abbott Laboratories Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio TMO (Thermo Scientific)|GE HealthCare - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio mt.com MTD|WAT: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Bio-Techne Corp|Enterprise Value to EBITDA Ratio BRKR|AZTA: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Varex Imaging (VREX)|Enterprise Value to EBITDA Ratio semlerscientific.com SMLR|EV/EBITDA Multiple BFLY (Butterfly Network)|Mesa Laboratories Inc (MLAB) - Company Value to EBITDA|Quantum-Si Corp - EV/EBITDA Multiple|NNOX (Nano-X Imaging Ltd) - Enterprise Value to Operating Income Before Depreciation|QTRX: EV/EBITDA Multiple|CV - Total Company Value to Operating Income Before Depreciation Ratio|MXCT (MaxCyte) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Rapid Micro (RPID)|EV/EBITDA Multiple SEER|EV/EBITDA Multiple Hyperfine Medical (HYPR)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization FONAR Corporation FONR|Daxor Corp - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|MDAI: Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation VIVS (Organovo Holdings)|ACON: EV/EBITDA Multiple|Company Value to EBITDA Akoya Biosciences, Inc. (AKYA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ThermoGenesis|TLIS - Enterprise Value to EBITDA Multiple|Enterprise Value to EBITDA Ratio TTOO (T2 Biosystems)